A mouse model of familial hypertrophic cardiomyopathy caused by a -tropomyosin mutation

By Prabhakar R.   Petrashevskaya N.   Schwartz A.   Aronow B.   Boivin G.P.   Molkentin J.D.   Wieczorek D.F.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 33-42

Springer Publishing Company

Access to resources Recommend Favorite

Identification of Two Novel Insulin Receptor Mutations, Asp59Gly and Leu62Pro, in Type A Syndrome of Extreme Insulin Resistance

By Rouard M.   Macari F.   Bouix O.   Lautier C.   Brun J.F.   Lefebvre P.   Renard E.   Bringer J.   Jaffiol C.   Grigorescu F.  

Biochemical and Biophysical Research Communications, Vol. 234, Iss. 3, 1997-05 ,pp. : 764-768

Elsevier

Access to resources Recommend Favorite

Ca 2+ -Dependent Binding of Calcyclin to Muscle Tropomyosin

By Golitsina N.L.   Kordowska J.   Wang C.-.L.A.   Lehrer S.S.  

Biochemical and Biophysical Research Communications, Vol. 220, Iss. 2, 1996-03 ,pp. : 360-365

Elsevier

Access to resources Recommend Favorite

Mutations in &bgr;-Myosin S2 that cause Familial Hypertrophic Cardiomyopathy (FHC) Abolish the Interaction with the Regulatory Domain of Myosin-binding Protein-C

By Gruen M.   Gautel M.  

Journal of Molecular Biology, Vol. 286, Iss. 3, 1999-02 ,pp. : 933-949

Academic Press

Access to resources Recommend Favorite

Phospholamban Gene Mutations Are Not Associated with Hypertrophic Cardiomyopathy in a Northern Greek Population

By Kalemi Theodora   Efthimiadis Georgios   Zioutas Dimitrios   Lambropoulos Alexandros   Mitakidou Anastasia   Giannakoulas Georgios   Vassilikos Vassilios   Karvounis Haralambos   Kotsis Alexandros   Parharidis Georgios   Louridas Georgios  

Biochemical Genetics, Vol. 43, Iss. 11-12, 2005-12 ,pp. : 637-642

Springer Publishing Company

Access to resources Recommend Favorite